JPH10120561A - Skin preparation for improving sputum for external use - Google Patents

Skin preparation for improving sputum for external use

Info

Publication number
JPH10120561A
JPH10120561A JP27665696A JP27665696A JPH10120561A JP H10120561 A JPH10120561 A JP H10120561A JP 27665696 A JP27665696 A JP 27665696A JP 27665696 A JP27665696 A JP 27665696A JP H10120561 A JPH10120561 A JP H10120561A
Authority
JP
Japan
Prior art keywords
action
skin
treatment
external preparation
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP27665696A
Other languages
Japanese (ja)
Inventor
Masanori Kosuge
正規 小菅
Takuo Kosuge
卓夫 小菅
Nobuhiro Ando
信裕 安藤
Yoshie Muramatsu
宜江 村松
Mitsuo Kawai
充夫 河合
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOKUTAAZU KOSUMETEIKUSU KK
Pola Chemical Industries Inc
Original Assignee
DOKUTAAZU KOSUMETEIKUSU KK
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOKUTAAZU KOSUMETEIKUSU KK, Pola Chemical Industries Inc filed Critical DOKUTAAZU KOSUMETEIKUSU KK
Priority to JP27665696A priority Critical patent/JPH10120561A/en
Publication of JPH10120561A publication Critical patent/JPH10120561A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain the subject skin preparation containing a hydroxy fatty acid and capable of improving the action of sputum. SOLUTION: The skin preparation contains a hydroxy fatty acid or its salt as an active ingredient. The hydroxy fatty acid includes 10-hydroxydecenoic acid, and is contained in an amount to 0.001-10wt.%, preferably 0.01-5wt.%, based on the whole amount of the skin preparation. The skin preparation has a beautifully skin-whitening action, an atopic dermatitis-treating action, a dermatitis group-treating action, a dermatomycosis-treating action, a verruca-treating action, a dyspigmentation-treating action, a psoriasis vulgaris-treating action, a senile xeroderma-treating action, a senile keratoma-treating action, a skin damage-treating action, a hair growth-stimulating action, a perspiration- stimulating action, a digestive juice secretion-stimulating action, a diuretic action, a dejection-stimulating action, etc. The preparation is effective for preventing the decline of skin, treating atopic dermatitis, preventing the crisis and exacerbation of the atopic dermatitis, stimulating the growth of hair, preventing the falling of hair, improving eczema, preventing the exacerbation of the eczema, stimulating bowel movement and urination, etc.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、津液作用の改善に
有益な化粧料、医薬等の皮膚外用剤に関する。
TECHNICAL FIELD The present invention relates to an external preparation for skin such as cosmetics and medicines, which is useful for improving the action of tsukusu.

【0002】[0002]

【従来の技術】漢方思想における気、血、水の考え方
は、その薬理作用の捉え方のユニークさと、漢方薬選択
時の合理的な指標であるために、古くより研究されてき
た。これらの内、気、血の意味するものについては、多
くのことが解明されてきた。例えば、血とは酸素、栄養
等エネルギーを中心とする補給・代謝を表すキーワード
であり、気とは生命活動の恒常性機構の活動状況と生命
活動の原動力の状況を表すキーワードであることが知ら
れている。
2. Description of the Related Art The concept of qi, blood, and water in Chinese medicine has long been studied because of its uniqueness in understanding its pharmacological action and a rational index for selecting Chinese medicine. Of these, many have been elucidated about the meanings of qi and blood. For example, it is known that blood is a keyword that represents the supply and metabolism mainly of energy such as oxygen and nutrition, and ki is a keyword that represents the status of the homeostasis of life activity and the status of the driving force of life activity. Have been.

【0003】しかし、水(津液)の働きについては老廃
物の代謝・排泄作用のみしか知られておらず、気・血・
水の論理体型において遅れて認識された為、その真の作
用(津液作用)の解明は未完であった。また、津液作用
と現代医学で認識されている種々の薬理作用等との関係
や津液の現代医学における役割などはあまり知られてお
らず、現代医学の分野における津液作用の解明及び津液
作用の改善をもたらす化粧料、医薬等の開発が望まれて
いた。
[0003] However, only the metabolism and excretion of waste products is known for the function of water (tsu liquor).
Since the recognition was delayed in the logical form of water, the elucidation of its true action (Tsukumi action) was incomplete. Also, little is known about the relationship between the pulp action and the various pharmacological actions recognized in modern medicine, and the role of pulp in modern medicine. The development of cosmetics, medicines, etc. that bring about such problems has been desired.

【0004】[0004]

【発明が解決しようとする課題】本発明はこのような状
況を踏まえてなされたものであり、津液の真の作用を明
らかにし、津液作用の改善に用いられる皮膚外用剤を提
供することを課題とする。
DISCLOSURE OF THE INVENTION The present invention has been made in view of such circumstances, and has as its object to clarify the true function of a tsuju and to provide an external preparation for skin used to improve the action of a tsuku. And

【0005】[0005]

【課題を解決するための手段】本発明者等は、このよう
な状況に鑑み、津液の真の作用を求めて鋭意研究を重ね
た結果、津液作用が、ある種の物質の働きによって水分
の体外への分泌を司る器官を刺激し、体内水分の体外へ
の分泌を促進させる作用を意味していることを見いだし
た。そして、そのような分泌器官を刺激し津液作用を促
進・改善しうる物質について検討した結果、本発明を完
成した。
Means for Solving the Problems In view of such a situation, the present inventors have conducted intensive studies in search of the true function of tsuju. It was found that it stimulates the organs responsible for extracorporeal secretion and promotes the secretion of body water out of the body. Then, as a result of examining substances capable of stimulating such secretory organs and promoting / improving the action of the pulp, the present invention was completed.

【0006】すなわち、本発明は、ヒドロキシ脂肪酸及
びその生理的に許容される塩からなる群から選ばれる1
種又は2種以上を有効成分とする津液改善用皮膚外用剤
を提供するものである。
[0006] That is, the present invention relates to a compound selected from the group consisting of hydroxy fatty acids and physiologically acceptable salts thereof.
It is intended to provide a skin external preparation for tsumugi improvement containing one or more kinds of active ingredients.

【0007】本発明者らは、津液作用が、真皮から表皮
への水分分泌を促進し表皮に十分な水分を保持させるこ
とによって起こる美肌作用、アトピー性皮膚炎、湿疹、
皮膚真菌症、疣贅、色素沈着症、尋常性乾癬、老人性乾
皮症、老人性角化腫、火傷等の各種皮膚疾患治療作用、
発毛促進作用、発汗促進作用、胃壁、腎臓、腸管での水
分分泌を促進させることによって起こる消化液分泌促進
作用、利尿作用、便通促進作用にかかわる作用であるこ
とを見出した。
[0007] The present inventors have found that the essence of the tanning solution, which promotes the secretion of water from the dermis to the epidermis and causes the epidermis to retain sufficient moisture, atopic dermatitis, eczema,
Dermatomycosis, warts, pigmentation, psoriasis vulgaris, senile xeroderma, senile keratoma, therapeutic effects on various skin diseases such as burns,
It has been found that the action is related to a hair growth promoting action, a sweat promoting action, a digestive juice secretion promoting action, a diuretic action and a bowel movement promoting action caused by promoting water secretion in the stomach wall, kidney and intestinal tract.

【0008】すなわち、漢方生薬の薬効分類を詳細に検
討し、現代医薬分類との対比を行った結果、水(津液)
が関与すると言われている、しゃ下、利水、消導、補陰
と言った薬草群の作用が現代医薬品分類における美肌作
用、アトピー性皮膚炎治療作用、湿疹で代表される皮膚
炎群治療作用、皮膚真菌症治療作用、疣贅治療作用、肝
炎で代表される色素沈着症治療作用、尋常性乾癬治療
症、老人性乾皮症、老人性角化腫治療作用、物理的原因
による皮膚損傷治療作用、発毛促進作用、消化液分泌促
進作用、発汗促進作用、利尿作用、便通促進作用と係わ
りが深いことを見いだした。
[0008] That is, the medicinal classification of Chinese herbal medicines was examined in detail, and compared with modern medicine classifications.
It is said that the effects of the herbs such as shampoo, irrigation, conduction and prosthesis are related to beautiful skin effect, atopic dermatitis treatment, and dermatitis group treatment represented by eczema in the modern pharmaceutical classification. , Dermatomycosis treatment, wart treatment, pigmentation such as hepatitis, psoriasis vulgaris, senile xeroderma, senile keratoma treatment, skin damage treatment due to physical causes It has been found that it is closely related to the action, the hair growth promoting action, the digestive juice secretion promoting action, the sweating promoting action, the diuretic action and the bowel movement promoting action.

【0009】この知見をもとに種々の物質について美肌
作用、アトピー性皮膚炎治療作用、発毛促進作用、湿疹
の治療作用、消化液分泌促進作用、発汗促進作用を指標
にスクリーニングを重ねたところ、ヒドロキシ脂肪酸又
はその生理的に許容される塩がこのような作用に優れる
ことを見いだした。更に驚くべきことに、ヒドロキシ脂
肪酸又はその生理的に許容される塩を外用投与すること
により、胃酸等の消化液の分泌が促されるなどの効果が
あることを見出し、本発明を完成させるに至った。
Based on this finding, screening was carried out on various substances based on their beautifying effect, therapeutic effect on atopic dermatitis, promoting hair growth, treating eczema, promoting secretion of digestive juice, and promoting sweating. It has been found that hydroxy fatty acids or physiologically acceptable salts thereof are excellent in such effects. More surprisingly, it has been found that the topical administration of a hydroxy fatty acid or a physiologically acceptable salt thereof has an effect of promoting secretion of digestive juices such as stomach acid, and has led to the completion of the present invention. Was.

【0010】ヒドロキシ脂肪酸又はその生理的に許容さ
れる塩が経皮吸収促進作用、肝機能の改善や免疫機能の
改善作用を有していることは知られているものの、真の
意味での津液改善作用があることは知る余地もなかっ
た。更に、ヒドロキシ脂肪酸又はその生理的に許容され
る塩が美肌作用、アトピー性皮膚炎、湿疹、皮膚真菌
症、疣贅、色素沈着症、尋常性乾癬、老人性乾皮症、老
人性角化腫、火傷等の皮膚疾患治療作用、発毛促進作
用、発汗促進作用、消化液分泌促進作用、利尿作用、便
通促進作用を有することは全く知られていなかった。
Although it is known that hydroxy fatty acids or physiologically acceptable salts thereof have a transdermal absorption-promoting action, a liver function-improving action and an immune function-improving action, the essence of Tsutsumi There was no room for improvement. Furthermore, hydroxy fatty acids or physiologically acceptable salts thereof are effective in skin beautifulning, atopic dermatitis, eczema, dermatomycosis, warts, pigmentation, psoriasis vulgaris, senile xerosis, senile keratoma It has never been known that it has an action for treating skin diseases such as burns, an action for promoting hair growth, an action for promoting sweating, an action for promoting digestive juice secretion, an action for diuresis, and an action for promoting bowel movement.

【0011】[0011]

【発明の実施の形態】以下に、本発明の実施の形態を説
明する。本発明の津液改善用皮膚外用剤は、ヒドロキシ
脂肪酸及びその生理的に許容される塩からなる群から選
ばれる1種又は2種以上を有効成分とする。ヒドロキシ
脂肪酸としては、10−ヒドロキシデセン酸、イプロリ
ン酸、ヒドロキシミリスチン酸、9,10−ジヒドロキ
シオレイン酸等が例示でき、これらがいずれも使用でき
る。このうち、ヒドロキシミリスチン酸としては、水酸
基の位置により種々の異性体が存在するが、これらのう
ちでは、漢方生薬である商陸由来のものが取り分け好ま
しい。
Embodiments of the present invention will be described below. The skin external preparation for tsumuage improvement of the present invention contains one or more active ingredients selected from the group consisting of hydroxy fatty acids and physiologically acceptable salts thereof. Examples of the hydroxy fatty acid include 10-hydroxydecenoic acid, iprolic acid, hydroxymyristic acid, 9,10-dihydroxyoleic acid, and the like, and any of them can be used. Among these, hydroxymyristic acid has various isomers depending on the position of the hydroxyl group, and among them, those derived from commercial land, which is a Chinese herbal medicine, are particularly preferable.

【0012】ヒドロキシ脂肪酸の生理的に許容される塩
としては、例えば、ナトリウム、カリウム等のアルカリ
金属塩、カルシウム、マグネシウム等のアルカリ土類金
属塩、アンモニウム塩、トリエチルアミンやトリエタノ
ールアミン等の有機アミン塩、リジンやアルギニン等の
塩基性アミノ酸塩等が好ましく例示できる。これらの対
塩基は1種でも2種以上で組み合わせて用いても構わな
い。これらのヒドロキシ脂肪酸又はその生理的に許容さ
れる塩はいずれも市販されており、入手可能である。
Examples of physiologically acceptable salts of hydroxy fatty acids include alkali metal salts such as sodium and potassium, alkaline earth metal salts such as calcium and magnesium, ammonium salts, and organic amines such as triethylamine and triethanolamine. Preferred examples include salts, basic amino acid salts such as lysine and arginine. These counterbases may be used alone or in combination of two or more. All of these hydroxy fatty acids or physiologically acceptable salts thereof are commercially available and available.

【0013】本発明の皮膚外用剤としては、基礎化粧料
やメークアップ化粧料、頭髪用化粧料、浴用剤などの化
粧料や、抗炎症外用剤等の皮膚外用医薬組成物が例示で
きる。本発明の皮膚外用剤におけるヒドロキシ脂肪酸又
はその生理的に許容される塩の好ましい含有量は、皮膚
外用剤全体に対し0.001〜10重量%であり、より
好ましくは0.01〜5重量%であり、更に好ましくは
0.01〜3重量%である。
Examples of the external preparation for skin of the present invention include cosmetics such as basic cosmetics, make-up cosmetics, hair cosmetics, bath preparations and the like, and skin external pharmaceutical compositions such as anti-inflammatory external preparations. The preferred content of the hydroxy fatty acid or the physiologically acceptable salt thereof in the skin external preparation of the present invention is 0.001 to 10% by weight, more preferably 0.01 to 5% by weight, based on the whole skin external preparation. And more preferably 0.01 to 3% by weight.

【0014】本発明の皮膚外用剤は、ヒドロキシ脂肪酸
又はその生理的に許容される塩以外に、化粧料、皮膚外
用医薬組成物等で通常用いられている任意成分を含有す
ることができる。このような任意成分としては、ワセリ
ンやマイクロクリスタリンワックス等のような炭化水素
類、ホホバ油やゲイロウ等のエステル類、牛脂、オリー
ブ油等のトリグリセライド類、セタノール、オレイルア
ルコール等の高級アルコール類、ステアリン酸、オレイ
ン酸等の脂肪酸、グリセリンや1,3−ブタンジオール
等の多価アルコール類、非イオン界面活性剤、アニオン
界面活性剤、カチオン界面活性剤、両性界面活性剤、エ
タノール、カーボポール等の増粘剤、防腐剤、紫外線吸
収剤、抗酸化剤、色素、粉体類等が例示できる。これら
の任意成分とヒドロキシ脂肪酸又はその生理的に許容さ
れる塩とを常法に従って処理することにより、本発明の
皮膚外用剤を製造することができる。
The external preparation for skin of the present invention may contain, in addition to the hydroxy fatty acid or a physiologically acceptable salt thereof, optional components commonly used in cosmetics, external pharmaceutical compositions for skin and the like. Such optional components include hydrocarbons such as petrolatum and microcrystalline wax, esters such as jojoba oil and gay wax, triglycerides such as tallow, olive oil, higher alcohols such as cetanol and oleyl alcohol, and stearic acid. Fatty acids such as oleic acid, polyhydric alcohols such as glycerin and 1,3-butanediol, nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, ethanol, carbopol, etc. Examples include a thickener, a preservative, an ultraviolet absorber, an antioxidant, a pigment, and powders. The external preparation for skin of the present invention can be produced by treating these optional components with a hydroxy fatty acid or a physiologically acceptable salt thereof according to a conventional method.

【0015】本発明の津液改善用皮膚外用剤は、津液作
用の促進・改善に用いられる。津液作用は、その発現形
態としてしゃ下作用、利水作用、補陰作用、消導作用と
して生体に発現することが知られている。これらの作用
を有する漢方生薬としては、しゃ下作用であれば、ダイ
オウ、バンシャヨウ、ロカイ、マシニン、ケンゴシ、カ
ンスイ、ゲンカ、ゾクズイシ、ウキュウコンピ等が知ら
れており、利水作用を有する漢方生薬としては、チョレ
イ、ブクリョウ、タクシャ、インチンコウ、ヨクイニ
ン、トウカニン、ジフシ、トウキヒ、キンセンソウ等が
知られており、補陰作用を有する漢方生薬としては、シ
ャジン、セイヨウジン、テンモンドウ、バクモンドウ、
セッコク、ギョクチク、ヒャクゴウ、ソウキセイ、カン
レンソウ、ジョテイシ、ゴマ、コクズ、キバン、ベッコ
ウ等が知られており、消導作用を有する漢方生薬として
は、サンザシ、クレンコンピ、ヒシ、カクシツ、ライガ
ン、ビンロウジ、ナンカシ、タイサン等が知られてい
る。
[0015] The skin external preparation for improving tidal fluid of the present invention is used for promoting and improving the tidal fluid action. It is known that the tsuju action is expressed in a living body as a mode of expression, such as a shampooing action, a water-supplying action, a prosthesis action, and a conduction action. As a herbal crude drug having these effects, if it is a shampooing effect, rhubarb, banshayou, rokai, machinin, kengoshi, Kansui, Genka, Zokuzuishi, kyukyu compi, etc. Chorei, Bukuryo, Taksha, Inchinko, Jokuinin, Toukanin, Difushi, Tokhihi, Kinsenso and the like are known, and as herbal crude drugs having a prosthetic effect, Shajin, Eurasia, Tenmondou, Bakumondou,
Ginseng, arctic, antelope, sycamore, renren, jotenishi, sesame, kokuzu, kiban, bekko are known, and as a herbal crude drug having an antidepressant effect, hawthorn, krenkonpi, hishi, kakushitsu, reigan, areca, nankashi, Taisan and the like are known.

【0016】これらについての文献等を調べてみると、
美肌作用、発毛促進作用、抗アレルギー作用、抗炎症作
用、消化促進作用等の薬理作用が重複していることが見
出された。ここに本発明者等は注目し、「水」(津液)
の作用は現代医学における美肌作用、アトピー性皮膚
炎、湿疹、皮膚真菌症、疣贅、色素沈着症、尋常性乾
癬、老人性乾皮症、老人性角化腫、火傷等の皮膚疾患の
治療作用、発毛促進作用、吹き出物の治療作用、消化液
分泌促進作用、発汗促進作用、利尿作用、便通促進作用
等を指標とすることができることを見出した。尚、これ
らの作用の一つを有する物質は、大なり小なり他の作用
も有している場合が多い。したがって、これらの作用の
一つを指標にするスクリーニングを行えば、他の作用の
推定を行うこともできる。
Examining the literature and the like about these,
It has been found that pharmacological actions such as beautifying action, hair growth-promoting action, anti-allergic action, anti-inflammatory action, and digestion promoting action overlap. Here, the present inventors pay attention, and consider "water" (Tsu liquid).
Works in modern medicine to treat skin disorders such as skin beautification, atopic dermatitis, eczema, dermatomycosis, warts, pigmentation, psoriasis vulgaris, senile xeroderma, senile keratoma and burns It has been found that the action, the hair growth promoting action, the therapeutic action of pimples, the digestive juice secretion promoting action, the sweat promoting action, the diuretic action, the bowel movement promoting action and the like can be used as indices. In addition, substances having one of these actions often have other actions to a greater or lesser degree. Therefore, if screening is performed using one of these actions as an index, other actions can be estimated.

【0017】本発明の津液改善用皮膚外用剤は、美肌作
用、アトピー性皮膚炎治療作用、湿疹で代表される皮膚
炎群治療作用、皮膚真菌症治療作用、疣贅治療作用、肝
炎で代表される色素沈着症治療作用、尋常性乾癬治療
症、老人性乾皮症、老人性角化腫治療作用、物理的原因
による皮膚損傷治療作用、発毛促進作用、消化液分泌促
進作用、発汗促進作用、便通促進作用、及び排尿促進
(利尿)作用からなる群から選ばれる少なくとも一つを
改善する作用を有しており、これを用いることにより、
肌の衰えの防止と改善、アトピー性皮膚炎の治療と発症
・悪化の防止、発毛の促進と抜け毛の予防、湿疹の改善
と悪化の予防、便通の促進と排尿の促進等の効果が発揮
される。
The skin external preparation for improving a tanning solution of the present invention is represented by a skin beautiful action, an atopic dermatitis treatment action, a dermatitis group treatment action represented by eczema, a dermatomycosis treatment action, a wart treatment action, and hepatitis. Therapeutic action for pigmentation disease, psoriasis vulgaris, senile xeroderma, senile keratoma, skin damage treatment due to physical causes, hair growth promoting action, digestive secretion promoting action, sweat promoting action Has a function to improve at least one selected from the group consisting of a bowel movement promoting action, and a urination promoting (diuretic) action, and by using this,
Exhibits the effects of preventing and improving skin deterioration, treating atopic dermatitis and preventing the onset and worsening, promoting hair growth and preventing hair loss, improving and preventing eczema, promoting bowel movements and promoting urination. Is done.

【0018】本発明の皮膚外用剤の好ましい投与量は、
疾病の種類や患者の特性によって異なるが、適当量を患
部皮膚や健常皮膚の一部又は全体に適当量一日一回乃至
は数回塗布すればよい。
The preferred dosage of the external preparation for skin of the present invention is
The appropriate amount may be applied once or several times a day to a part or the whole of the affected skin or healthy skin, depending on the kind of the disease and the characteristics of the patient.

【0019】取り分け本発明で注目すべきことは、本発
明のヒドロキシ脂肪酸又はその生理的に許容される塩
は、経皮投与によって胃酸などの消化液の分泌が促進さ
れる等の効果を有する点であり、経皮投与でこのような
作用を同時に期待しうる物質は未だ知られていない。
In particular, it should be noted that the hydroxy fatty acid of the present invention or a physiologically acceptable salt thereof has effects such as promotion of secretion of digestive juices such as stomach acid by transdermal administration. However, there is no known substance capable of simultaneously expecting such an effect by transdermal administration.

【0020】[0020]

【実施例】以下に、本発明の実施例を説明する。尚、表
中の処方の数値の単位は重量部である。
Embodiments of the present invention will be described below. The unit of the numerical value of the prescription in the table is part by weight.

【0021】[0021]

【実施例1〜5】 <配合例>下記表1に示す処方に従って皮膚外用剤(ク
リーム)を作成した。即ち、(イ)、(ロ)、(ハ)の
各成分群をそれぞれ80℃で加熱し、(イ)をよく混練
し、これに(ロ)を加えて希釈し、更にこれに(ハ)を
徐々に加えて乳化し、撹拌冷却して皮膚外用剤を得た。
このものは安全性も高く、下記試験例に示すように優れ
た津液作用を有するので、医薬組成物としても化粧料と
しても有用である。
Examples 1 to 5 <Formulation Examples> Skin external preparations (creams) were prepared according to the formulations shown in Table 1 below. That is, each of the component groups (a), (b) and (c) is heated at 80 ° C., (a) is kneaded well, (b) is added thereto, diluted, and (c) Was gradually added and emulsified, followed by stirring and cooling to obtain a skin external preparation.
It is highly safe and has an excellent essence as shown in the following test examples, and is therefore useful as a pharmaceutical composition and as a cosmetic.

【0022】[0022]

【表1】 [Table 1]

【0023】[0023]

【実施例6〜10】 <配合例>下記表2に示す成分を用いその処方に従っ
て、皮膚外用剤(軟膏)を作成した。即ち、各処方成分
をニーダーに秤込み、よく混練して軟膏を得た。
Examples 6 to 10 <Formulation Examples> A skin external preparation (ointment) was prepared using the components shown in Table 2 below and according to the formulation. That is, each prescription component was weighed into a kneader and kneaded well to obtain an ointment.

【0024】[0024]

【表2】 [Table 2]

【0025】[0025]

【実施例11〜15】 <配合例>下記表3に示す成分を用いてその処方に従っ
て、頭髪用皮膚外用剤(ヘアトニック)を作成した。即
ち、各処方成分を室温で撹拌可溶化し、ヘアトニックを
得た。
Examples 11 to 15 <Formulation Example> An external preparation for hair for hair (hair tonic) was prepared using the components shown in Table 3 below and according to the formulation. That is, each formulation component was stirred and solubilized at room temperature to obtain a hair tonic.

【0026】[0026]

【表3】 [Table 3]

【0027】[0027]

【実施例16〜20】 <配合例>下記表4に示す成分を用いその処方に従っ
て、浴用剤を作成した。即ち、各処方成分をニーダーで
混練し浴用剤を得た。
Examples 16 to 20 <Formulation Examples> Bath ingredients were prepared using the components shown in Table 4 below and according to the formulations. That is, the respective components were kneaded with a kneader to obtain a bath agent.

【0028】[0028]

【表4】 [Table 4]

【0029】[0029]

【実施例21】 <試験例1:美肌改善作用>肌荒れに悩む29〜39歳
のパネラー1群10名が、上記実施例1〜3の皮膚外用
剤(0.02g)を1日朝晩2回ずつ2ヶ月間患部に塗
布し、肌荒れの改善効果を評価した。評価の基準は、非
常に改善した(評点5)〜改善しない(評点0)、とし
た。対照としては、本発明の有効成分であるヒドロキシ
脂肪酸又はその生理的に許容される塩を水で置換したも
のを用いた。結果を平均評点として表5に示す。これよ
り、本発明の皮膚外用剤が肌荒れを改善する作用を有す
ること、即ち、美肌作用を有することがわかる。即ち、
本発明のヒドロキシ脂肪酸又はその生理的に許容される
塩がこのような作用を有することがわかる。
Example 21 <Test Example 1: Improving Beautiful Skin> Ten panelists, 29 to 39 years old, suffering from rough skin, applied the skin external preparations (0.02 g) of Examples 1 to 3 twice daily in the morning and evening. Each was applied to the affected area for two months, and the effect of improving skin roughness was evaluated. The evaluation criteria were very improved (gradation 5) to not improved (gradation 0). As a control, a hydroxy fatty acid or a physiologically acceptable salt thereof, which is an active ingredient of the present invention, was replaced with water. The results are shown in Table 5 as average scores. This indicates that the external preparation for skin of the present invention has an effect of improving rough skin, that is, has a skin beautiful effect. That is,
It is understood that the hydroxy fatty acid of the present invention or a physiologically acceptable salt thereof has such an effect.

【0030】[0030]

【表5】 [Table 5]

【0031】[0031]

【実施例22】 <試験例2:発毛促進作用>C3Hマウス1群5匹の背
部を剃毛し、下記表6に示す検体10mgを生理食塩水
200μlに溶解又は分散させて塗布し、その後の毛の
生え方を観察して発毛促進作用を評価した。対照はベヒ
クルの生理食塩水のみとした。評価の基準は、++(評
点4):対照に比べて著しく早い、+(評点2):対照
に比べて早い、±(評点1):対照に比べてやや早い、
−(評点0):対照に比べて早くない、とした。結果を
平均評点として表6に示す。これより、本発明の皮膚外
用剤の有効成分であるヒドロキシ脂肪酸又はその生理的
に許容される塩は発毛促進作用に優れることがわかる。
Example 22 <Test Example 2: Hair growth promoting action> The back of 5 mice per group of C3H mice was shaved, and 10 mg of a sample shown in Table 6 below was dissolved or dispersed in 200 µl of physiological saline and applied. The hair growth promoting effect was evaluated by observing the hair growth. The control was vehicle saline only. The evaluation criteria are ++ (score 4): significantly earlier than the control, + (score 2): earlier than the control, ± (score 1): slightly earlier than the control,
-(Score 0): Not earlier than control. The results are shown in Table 6 as average scores. This shows that hydroxy fatty acid or a physiologically acceptable salt thereof, which is an active ingredient of the external preparation for skin of the present invention, has an excellent hair growth promoting action.

【0032】[0032]

【表6】 [Table 6]

【0033】[0033]

【実施例23】 <試験例3:アトピー性皮膚炎に対する作用>アトピー
性皮膚炎に悩む23〜39歳のパネラー1群10名が、
上記実施例1〜3の皮膚外用剤(0.02g)を1日朝
晩2回ずつ2ヶ月間患部に塗布し、アトピー性皮膚炎の
改善効果を評価した。評価の基準は、非常に改善した
(評点5)〜改善しない(評点0)、とした。対照とし
ては、本発明のヒドロキシ脂肪酸又はその生理的に許容
される塩を水に置換したものを用いた。結果を平均評点
として表7に示す。これより、本発明の皮膚外用剤はア
トピー性皮膚炎を改善する作用を有することがわかる。
即ち、本発明のヒドロキシ脂肪酸又はその生理的に許容
される塩がこのような作用を有することがわかる。
Example 23 <Test Example 3: Effect on atopic dermatitis> A group of 10 panelists aged 23 to 39 years old suffering from atopic dermatitis
The external preparation for skin (0.02 g) of the above Examples 1 to 3 was applied to the affected area twice a day and twice a day for 2 months to evaluate the effect of improving atopic dermatitis. The evaluation criteria were very improved (gradation 5) to not improved (gradation 0). As a control, the hydroxy fatty acid of the present invention or a physiologically acceptable salt thereof was replaced with water. The results are shown in Table 7 as average scores. This indicates that the external preparation for skin of the present invention has an effect of improving atopic dermatitis.
That is, it is understood that the hydroxy fatty acid of the present invention or a physiologically acceptable salt thereof has such an effect.

【0034】[0034]

【表7】 [Table 7]

【0035】[0035]

【実施例24】 <試験例4:湿疹治療作用>吹き出物に悩む19〜25
歳のパネラー1群10名が、上記実施例1〜3の皮膚外
用剤(0.02g)を1日朝晩2回ずつ2ヶ月間塗布
し、湿疹の改善効果を評価した。評価の基準は、非常に
改善した(評点5)〜改善しない(評点0)、とした。
対照としては、本発明のヒドロキシ脂肪酸又はその生理
的に許容される塩を水に置換したものを用いた。結果を
平均評点として表8に示す。これより、本発明の皮膚外
用剤の有効成分であるヒドロキシ脂肪酸又はその生理的
に許容される塩が湿疹を改善する作用を有することがわ
かる。
Example 24 <Test Example 4: Eczema treatment> 19-25 suffering from breakout
A group of 10-year-old panelists applied the skin external preparations of Examples 1 to 3 (0.02 g) twice a day for 2 months to evaluate the eczema improving effect. The evaluation criteria were very improved (gradation 5) to not improved (gradation 0).
As a control, the hydroxy fatty acid of the present invention or a physiologically acceptable salt thereof was replaced with water. The results are shown in Table 8 as average scores. This indicates that hydroxy fatty acid or a physiologically acceptable salt thereof, which is an active ingredient of the external preparation for skin of the present invention, has an effect of improving eczema.

【0036】[0036]

【表8】 [Table 8]

【0037】[0037]

【実施例25】 <試験例5:胃液分泌促進作用>麻酔犬を用いて胃液の
分泌促進を見た。即ち、ペントバルビツールで麻酔した
犬の胃に投与装置付き内視鏡を導入し、検体として表9
に示す本発明の皮膚外用剤の有効成分であるヒドロキシ
脂肪酸又はその生理的に許容される塩10mgを50%
エタノール水溶液200μlに溶解又は分散させて背部
に経皮投与し、その前後の胃液の分泌を観察して胃液分
泌促進作用を評価した。対照は生理食塩水のみを用い
た。評価の基準は、++(評点4):対照に比べて著し
く胃液分泌が増大、+(評点2):対照に比べて胃液分
泌が増大、±(評点1):対照に比べてやや分泌が増
大、−(評点0):分泌が対照に比べて増大せず、とし
た。結果を表9に示す。これより、本発明の有効成分で
あるヒドロキシ脂肪酸又はその生理的に許容される塩は
胃液分泌促進作用に優れることがわかる。
Example 25 <Test Example 5: Gastric secretion promoting action> The secretion of gastric juice was examined using an anesthetized dog. That is, an endoscope with an administration device was introduced into the stomach of a dog anesthetized with a pentobarbitur, and the specimen was used as a sample.
50% of a hydroxy fatty acid or a physiologically acceptable salt thereof as an active ingredient of the external preparation for skin of the present invention shown in
It was dissolved or dispersed in 200 μl of an aqueous ethanol solution and transdermally administered to the back, and the secretion of gastric juice before and after the dissolution was observed to evaluate the gastric secretion promoting action. As a control, only physiological saline was used. Evaluation criteria were as follows: ++ (score 4): gastric secretion increased significantly compared to control, + (score 2): increased gastric secretion compared to control, ± (score 1): slightly increased compared to control ,-(Score 0): the secretion did not increase compared to the control. Table 9 shows the results. This indicates that the hydroxy fatty acid or a physiologically acceptable salt thereof, which is an active ingredient of the present invention, has an excellent gastric secretion promoting action.

【0038】[0038]

【表9】 [Table 9]

【0039】[0039]

【実施例26】 <試験例6:便通・排尿の促進作用>ICRマウスを代
謝ケージで飼育した。投与群は、検体として上記実施例
1〜3の皮膚外用剤を、剃毛した背部皮膚に1g/1日
/1匹、毎日朝夕2回0.5gずつ、7日間塗布して経
皮投与した。最後の投与後24時間の尿と糞の量をモニ
ターした。コントロール群は検体を投与しなかった。各
サンプル1群10匹とした。検体投与群の尿量の総和を
コントロール群の尿量の総和で除した値と検体投与群の
糞量の総和をコントロール群の糞量の総和で除した値と
を表10に示す。これより本発明のヒドロキシ脂肪酸又
はその生理的に許容される塩は、便通促進作用及び排尿
促進作用(利尿作用)に優れることがわかる。
Example 26 <Test Example 6: Effect of promoting bowel movement and urination> ICR mice were bred in metabolic cages. In the administration group, the skin external preparations of Examples 1 to 3 were applied to the shaved back skin as a specimen at a rate of 1 g / day / animal, 0.5 g twice daily in the morning and evening, and transdermally administered for 7 days. . The amount of urine and feces 24 hours after the last dose was monitored. The control group received no specimen. Each group consisted of 10 animals. Table 10 shows the value obtained by dividing the total urine volume of the sample administration group by the total urine volume of the control group and the value obtained by dividing the total feces volume of the sample administration group by the total feces volume of the control group. This shows that the hydroxy fatty acid of the present invention or a physiologically acceptable salt thereof is excellent in the bowel movement promoting action and urination promoting action (diuretic action).

【0040】[0040]

【表10】 [Table 10]

【0041】[0041]

【発明の効果】本発明によれば、美肌作用、アトピー性
皮膚炎治療作用、湿疹で代表される皮膚炎群治療作用、
皮膚真菌症治療作用、疣贅治療作用、肝炎で代表される
色素沈着症治療作用、尋常性乾癬治療症、老人性乾皮
症、老人性角化腫治療作用、物理的原因による皮膚損傷
治療作用、発毛促進作用、消化液分泌促進作用、発汗促
進作用、便通促進作用、及び利尿作用からなる群から選
ばれる津液作用を改善しうる皮膚外用剤を提供すること
ができる。
According to the present invention, a beautiful skin effect, a therapeutic effect on atopic dermatitis, a therapeutic effect on a dermatitis group represented by eczema,
Treatment for dermatomycosis, treatment for warts, treatment for pigmentation such as hepatitis, treatment for psoriasis vulgaris, treatment for senile xeroderma, senile keratoma, treatment for skin damage due to physical causes It is possible to provide a skin external preparation capable of improving a tsukusu action selected from the group consisting of a hair growth promoting action, a digestive juice secretion promoting action, a sweating promoting action, a bowel movement promoting action, and a diuretic action.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 31/20 ABE A61K 31/20 ABE (72)発明者 安藤 信裕 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 村松 宜江 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 河合 充夫 神奈川県横浜市戸塚区柏尾町560 ポーラ 化成工業株式会社戸塚研究所内──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 31/20 ABE A61K 31/20 ABE (72) Inventor Nobuhiro Ando 27-1, Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa Prefecture Pola Chemical Industry Co., Ltd. (72) Inventor Yoshie Muramatsu Yoshikazu Muramatsu 27-1 Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa Pref.Pola Chemical Industry Co., Ltd. Inside Totsuka Laboratory Co., Ltd.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 ヒドロキシ脂肪酸及びその生理的に許容
される塩からなる群から選ばれる1種又は2種以上を有
効成分とする、津液改善用皮膚外用剤。
1. A skin external preparation for improving a tanning solution, comprising one or more active ingredients selected from the group consisting of hydroxy fatty acids and physiologically acceptable salts thereof.
【請求項2】 前記ヒドロキシ脂肪酸がコール酸であ
る、請求項1記載の皮膚外用剤。
2. The external preparation for skin according to claim 1, wherein the hydroxy fatty acid is cholic acid.
【請求項3】 前記ヒドロキシ脂肪酸及びその生理的に
許容される塩からなる群から選ばれる1種又は2種以上
を0.001〜10重量%含有する、請求項1又は2記
載の津液改善用皮膚外用剤。
3. The improvement according to claim 1, wherein the hydroxy fatty acid and one or more selected from the group consisting of physiologically acceptable salts thereof are contained in an amount of 0.001 to 10% by weight. External preparation for skin.
【請求項4】 化粧料である、請求項1〜3のいずれか
に記載の皮膚外用剤。
4. The external preparation for skin according to claim 1, which is a cosmetic.
【請求項5】 医薬である、請求項1〜3のいずれかに
記載の皮膚外用剤。
5. The external preparation for skin according to claim 1, which is a medicament.
【請求項6】 美肌作用、アトピー性皮膚炎治療作用、
皮膚炎群治療作用、皮膚真菌症治療作用、疣贅治療作
用、色素沈着症治療作用、尋常性乾癬治療症、老人性乾
皮症、老人性角化腫治療作用、皮膚損傷治療作用、発毛
促進作用、消化液分泌促進作用、発汗促進作用、便通促
進作用、及び利尿作用からなる群から選ばれる津液作用
の改善用である、請求項1〜5のいずれかに記載の皮膚
外用剤。
6. A beautiful skin effect, an atopic dermatitis treatment effect,
Dermatitis group treatment, dermatomycosis treatment, wart treatment, pigmentation treatment, psoriasis vulgaris, senile xerosis, senile keratoma treatment, skin damage treatment, hair growth The external preparation for skin according to any one of claims 1 to 5, which is used for improving a tsutsuma action selected from the group consisting of a promoting action, a digestive juice secretion promoting action, a sweating promoting action, a bowel movement promoting action, and a diuretic action.
JP27665696A 1996-10-18 1996-10-18 Skin preparation for improving sputum for external use Pending JPH10120561A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27665696A JPH10120561A (en) 1996-10-18 1996-10-18 Skin preparation for improving sputum for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27665696A JPH10120561A (en) 1996-10-18 1996-10-18 Skin preparation for improving sputum for external use

Publications (1)

Publication Number Publication Date
JPH10120561A true JPH10120561A (en) 1998-05-12

Family

ID=17572500

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27665696A Pending JPH10120561A (en) 1996-10-18 1996-10-18 Skin preparation for improving sputum for external use

Country Status (1)

Country Link
JP (1) JPH10120561A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000007557A1 (en) * 1998-08-01 2000-02-17 Beiersdorf Ag Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives
JP2002526433A (en) * 1998-09-22 2002-08-20 ロレアル Use of at least one 10-hydroxy-2-decenoic acid derivative in a composition for promoting skin desquamation
WO2005034938A1 (en) * 2003-10-07 2005-04-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Collagen productin enhancer and production process and use thereof
JP2009184955A (en) * 2008-02-06 2009-08-20 Maruzen Pharmaceut Co Ltd TYPE IV COLLAGEN PRODUCTION PROMOTER, TRANSGLUTAMINASE-1 PRODUCTION PROMOTER, SERINE PALMITOYLTRANSFERASE PRODUCTION PROMOTER, AQUAPORIN 3 PRODUCTION PROMOTER, INVOLUCRIN PRODUCTION PROMOTER, HMG-CoA REDUCTASE PRODUCTION PROMOTER AND ADENOSINE TRIPHOSPHATE PRODUCTION PROMOTER
JP2012507505A (en) * 2008-10-31 2012-03-29 リピッド ファーマシューティカルズ イーエイチエフ. Fatty acids for use as pharmaceuticals

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000007557A1 (en) * 1998-08-01 2000-02-17 Beiersdorf Ag Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives
JP2002526433A (en) * 1998-09-22 2002-08-20 ロレアル Use of at least one 10-hydroxy-2-decenoic acid derivative in a composition for promoting skin desquamation
WO2005034938A1 (en) * 2003-10-07 2005-04-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Collagen productin enhancer and production process and use thereof
JP5050350B2 (en) * 2003-10-07 2012-10-17 株式会社林原 Collagen production enhancer, its production method and use
JP2009184955A (en) * 2008-02-06 2009-08-20 Maruzen Pharmaceut Co Ltd TYPE IV COLLAGEN PRODUCTION PROMOTER, TRANSGLUTAMINASE-1 PRODUCTION PROMOTER, SERINE PALMITOYLTRANSFERASE PRODUCTION PROMOTER, AQUAPORIN 3 PRODUCTION PROMOTER, INVOLUCRIN PRODUCTION PROMOTER, HMG-CoA REDUCTASE PRODUCTION PROMOTER AND ADENOSINE TRIPHOSPHATE PRODUCTION PROMOTER
JP2012507505A (en) * 2008-10-31 2012-03-29 リピッド ファーマシューティカルズ イーエイチエフ. Fatty acids for use as pharmaceuticals

Similar Documents

Publication Publication Date Title
US5496827A (en) Compositions for the transdermal delivery of nutrients
JP5922715B2 (en) Composition for controlling and / or stabilizing conditions affecting the skin
JPH0940523A (en) Fibroblast proliferation promoter containing water extract form chlorella
JPH10114649A (en) Improver for aqueous body fluid and composition for oral administration comprising the same
JP6921440B2 (en) Composition for promoting melanin production containing thistle extract as an active ingredient
TW200306209A (en) Medicament for curing itching rough skin or sensitive skin and for skin whitening based on reducing production and/or release of stem cell factor
JPH10120579A (en) Skin preparation for improving sputum for external use
JPH10175859A (en) External preparation for skin for improving water (of chinese medicine idea)
CN108686023A (en) A kind of antipruritic moisturizing essential oil for treating geroderma itch
JP4583655B2 (en) Anti-allergic skin external composition
CN102335231B (en) Chinese medicinal moisturizing cream for treating chloasma as well as preparation method and application thereof
JPH10175854A (en) External preparation for skin for improving water (of chinese medicine idea)
JPH10120558A (en) Skin preparation for improving sputum for external use
JP4018764B2 (en) Skin preparation for improving tsunami
JPH10120561A (en) Skin preparation for improving sputum for external use
CN106039022A (en) Skin brightening and whitening traditional Chinese medicinal composition, skin brightening and whitening traditional Chinese medicinal preparation, skin brightening and whitening mask and preparation method
Yagil Cosmeceuticals: Camel and Other Milk–Natural Skin Maintenance
JPH10175868A (en) Water (of chinese medicine idea) improving composition
JPH10114665A (en) Improver for aqueous body fluid and composition for oral administration comprising the same
CN102218024A (en) Blain dispelling composition and application thereof in cosmetic
JP4049406B2 (en) Tsu fluid improving agent and composition for oral administration containing the same
KR20150057888A (en) Composition for antiobesity and cellulite reduction comprising Ishige okamurae extract
JPH10114652A (en) Improver for aqueous body fluid and composition for oral administration comprising the same
CN110269926A (en) Middle benefit gas, which is relaxed, warms up composition and its preparation method and application
CN111110595B (en) Vegetable protein emulsifiable paste, preparation method and application thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Effective date: 20070717

Free format text: JAPANESE INTERMEDIATE CODE: A131

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071120